Briacell Therapeutics Corp Stock Analysis
| BCTXW Stock | USD 0.11 0.01 10.00% |
BriaCell Therapeutics Corp is overvalued with Real Value of 0.11 and Hype Value of 0.07. The main objective of BriaCell Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what BriaCell Therapeutics Corp is worth, separate from its market price. There are two main types of BriaCell Therapeutics' stock analysis: fundamental analysis and technical analysis.
The BriaCell Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BriaCell Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. BriaCell Stock trading window is adjusted to America/New York timezone.
BriaCell |
BriaCell Stock Analysis Notes
The company had not issued any dividends in recent years. For more info on BriaCell Therapeutics Corp please contact William MD at 604-921-1810 or go to https://briacell.com.BriaCell Therapeutics Investment Alerts
| BriaCell Therapeutics is not yet fully synchronised with the market data | |
| BriaCell Therapeutics generated a negative expected return over the last 90 days | |
| BriaCell Therapeutics has high historical volatility and very poor performance | |
| BriaCell Therapeutics has some characteristics of a very speculative penny stock | |
| BriaCell Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (4.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BriaCell Therapeutics generates negative cash flow from operations | |
| BriaCell Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: BriaCell Therapeutics Corp. Short Interest Update - Defense World |
BriaCell Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.08 M.BriaCell Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.68) | (0.64) | |
| Return On Capital Employed | (1.06) | (1.11) | |
| Return On Assets | (0.67) | (0.64) | |
| Return On Equity | 4.84 | 5.08 |
Management Efficiency
BriaCell Therapeutics has return on total asset (ROA) of (1.5814) % which means that it has lost $1.5814 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.3681) %, meaning that it generated substantial loss on money invested by shareholders. BriaCell Therapeutics' management efficiency ratios could be used to measure how well BriaCell Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 5.08 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.64). At this time, BriaCell Therapeutics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 1.5 M in 2025, whereas Total Current Assets are likely to drop slightly above 4 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.28) | (0.26) | |
| Net Current Asset Value | 402 K | 357.4 K | |
| Tangible Asset Value | 675.2 K | 628.6 K | |
| Tangible Book Value Per Share | (0.29) | (0.28) | |
| Enterprise Value Over EBITDA | (50.73) | (53.26) | |
| Price Book Value Ratio | (473.60) | (449.92) | |
| Enterprise Value Multiple | (50.73) | (53.26) | |
| Price Fair Value | (473.60) | (449.92) | |
| Enterprise Value | 1.4 B | 1.4 B |
The management strategies employed by BriaCell Therapeutics' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
BriaCell Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BriaCell Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on BriaCell Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BriaCell Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bondarenko Jamieson over two weeks ago Acquisition by Bondarenko Jamieson of 28000 shares of BriaCell Therapeutics at 4.58 subject to Rule 16b-3 |
BriaCell Therapeutics Predictive Daily Indicators
BriaCell Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BriaCell Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About BriaCell Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BriaCell Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BriaCell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BriaCell Therapeutics. By using and applying BriaCell Stock analysis, traders can create a robust methodology for identifying BriaCell entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BriaCell Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.